Stay updated on Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    A new 'Sample Collection' item was added and the page revision updated to v3.5.4; the previous version v3.5.3 was removed.
    Difference
    0.2%
    Check dated 2026-05-18T03:41:39.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    Updates the ClinicalTrials.gov page’s displayed revision identifier (e.g., version v3.5.2 to v3.5.3), reflecting a site/software release rather than a change to the trial record.
    Difference
    0.0%
    Check dated 2026-04-26T08:07:12.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    Added a new release entry on 2026-04-13 with Revision: v3.5.2, replacing the previous Revision: v3.5.0 dated 2026-04-08.
    Difference
    0.1%
    Check dated 2026-04-19T01:26:27.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    Study record dates were updated with new entries on 2026-04-08 and 2026-04-09, and older entries were removed on 2026-04-02 and 2026-04-03.
    Difference
    0.1%
    Check dated 2026-04-11T20:59:26.000Z thumbnail image
  8. Check
    53 days ago
    Change Detected
    Summary
    Added updates dated 2026-04-02 and 2026-04-03, and removed updates dated 2026-03-26 and 2026-03-27.
    Difference
    0.1%
    Check dated 2026-04-04T19:05:14.000Z thumbnail image
  9. Check
    60 days ago
    Change Detected
    Summary
    Additions on 2026-03-26 and 2026-03-27 introduce Urinary bladder small cell neuroendocrine carcinoma as a listed condition; deletions on 2026-03-19 and 2026-03-20 remove two previously listed items, updating the study's documented condition scope.
    Difference
    0.1%
    Check dated 2026-03-28T13:47:32.000Z thumbnail image

Stay in the know with updates to Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial page.